Cancéropôle Est brings together 1,400 scientists and clinicians who join efforts to bring the latest innovations in terms of prevention, screening, diagnostic and therapeutic options in oncology to the 8.4 million inhabitants of the area that Cancéropôle covers (the Grand Est and Burgundy Franche-Comté regions).
Organising, coordinating, and strengthening cancer research by partnering with academic and clinical institutions and bringing together researchers (epidemiologists, biologists, physicists, computer scientists, mathematicians, robot engineers…), healthcare professionals, manufacturers, and patients is a top priority for the Cancéropôle Est.
Projects about new technologies, diagnostics, stratification, or cancer patient follow-up will be presented.
Wednesday 27th June
10:30 AM – 11:30 AM | Session 1 : Innovation in cancer
Chemical Fusion: A General Method for Equimolar Linking Proteins and Payloads
Sasha Koniev, CEO (Syndivia) – Strasbourg
PREDMED® TEST, an innovative in vitro assay (IVDMIA) to identify the most adapted targeted therapies for patients affected with a solid tumor
Justine FRITZ (PhD), Project manager (ADAPTHERAPY) – Strasbourg
TAX2 peptide : from discovery to clinical development
Albin Jeanne (IR SATT-Nord) – Reims
Circulating HSP70-exosomes as cancer biomarker
Jessica Gobbo (CGFL) – Dijon
Active Personalised Cancer Immunotherapy
Jean-Marc Limacher (ODIMMA) – Colmar
11:30 AM – 12:30 PM | Session 2 : Big data and cancer
Radiomics and Anthropometry: how to get more from medical images for personalized medicine.
Pierre DECAZES, Centre de Lutte Contre le Cancer, Henri Becquerel, Normandie-Rouen
Automatic Segmentation using artificial intelligence of Kidney tumours in children (ASKid)
Florent MARIE (FEMTO-ST DISC) – Besançon
Rare is beautiful: explosing Big Data streams in rare genetic diseases
Kirsley CHENNEN (CSTB/IGBMC) – Strasbourg (Illkirch)
More information: www.canceropole-est.org